Literature DB >> 9116303

Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions.

G A Barabino1, R J Wise, V A Woodbury, B Zhang, K A Bridges, R P Hebbel, J Lawler, B M Ewenstein.   

Abstract

Sickle red blood cell (RBC) adhesion to the blood vessel wall is hypothesized to be the initiating event in the periodic vaso-occlusive episodes that characterize sickle cell disease (SCD). Thrombospondin-1 (TSP) and von Willebrand factor (vWF) have each been implicated in the adhesion of sickle RBC to vascular endothelial cells (EC) and subendothelial matrices. To better understand the contributions of each of these adhesive glycoproteins, we examined the adhesion of sickle RBC to immobilized TSP and vWF using a parallel plate flow chamber. Under postcapillary venular shear stress (1 dyne/cm2), sickle RBC adhered preferentially to TSP. To explore potential interactive effects of vWF and TSP, we examined sickle RBC adhesion to mixtures of these proteins. Whether the proteins were first combined in solution or sequentially applied to the slide, the presence of vWF inhibited the binding of sickle RBC to TSP. The inhibition of adhesion by vWF was shown to be the result of specific and saturable binding of vWF to TSP. Furthermore, vWF in solution at normal plasma levels also inhibited RBC adhesion to immobilized TSP. These data indicate that sickle RBC adhesion in vivo may be significantly influenced by the relative concentrations of TSP and vWF in the vascular wall.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116303

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

2.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

3.  Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction.

Authors:  J E Brittain; K J Mlinar; C S Anderson; E P Orringer; L V Parise
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice.

Authors:  Prem Prakash; Paresh P Kulkarni; Anil K Chauhan
Journal:  Blood       Date:  2014-10-24       Impact factor: 22.113

Review 5.  Emerging point-of-care technologies for sickle cell disease screening and monitoring.

Authors:  Yunus Alapan; Arwa Fraiwan; Erdem Kucukal; M Noman Hasan; Ryan Ung; Myeongseop Kim; Isaac Odame; Jane A Little; Umut A Gurkan
Journal:  Expert Rev Med Devices       Date:  2016-11-22       Impact factor: 3.166

6.  Restoration of retinal development in Vsx2 deficient mice by reduction of Gdf11 levels.

Authors:  Rosaysela Santos; Jeffry Wu; Jason A Hamilton; Rita Pinter; Robert Hindges; Anne L Calof
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis.

Authors:  T R Kyriakides; Y H Zhu; L T Smith; S D Bain; Z Yang; M T Lin; K G Danielson; R V Iozzo; M LaMarca; C E McKinney; E I Ginns; P Bornstein
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

8.  Interaction of von Willebrand factor with blood cells in flow models: a systematic review.

Authors:  Ryanne A Arisz; Judith J de Vries; Saskia E M Schols; Jeroen C J Eikenboom; Moniek P M de Maat
Journal:  Blood Adv       Date:  2022-07-12

9.  Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.

Authors:  Yunus Alapan; Ceonne Kim; Anima Adhikari; Kayla E Gray; Evren Gurkan-Cavusoglu; Jane A Little; Umut A Gurkan
Journal:  Transl Res       Date:  2016-03-19       Impact factor: 7.012

10.  Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.

Authors:  M Al Huneini; S Alkindi; V Panjwani; K Al Falahi; B Al Balushi; D Gravell; C H Ho; R Krishnamoorthy; A V Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-04-20       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.